MRSH Investing Cash Flow increased by 80.1% to -$104.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 500.0%, from $26.00M to -$104.00M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -7.7% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$357.00M | -$148.00M | -$592.00M | -$159.00M | -$99.00M | -$105.00M | -$487.00M | -$368.00M | -$133.00M | -$442.00M | -$474.00M | -$368.00M | -$415.00M | -$393.00M | -$7.65B | $26.00M | -$121.00M | -$227.00M | -$523.00M | -$104.00M |
| QoQ Change | — | +58.5% | -300.0% | +73.1% | +37.7% | -6.1% | -363.8% | +24.4% | +63.9% | -232.3% | -7.2% | +22.4% | -12.8% | +5.3% | <-999% | +100.3% | -565.4% | -87.6% | -130.4% | +80.1% |
| YoY Change | — | — | — | — | +72.3% | +29.1% | +17.7% | -131.4% | -34.3% | -321.0% | +2.7% | +0.0% | -212.0% | +11.1% | <-999% | +107.1% | +70.8% | +42.2% | +93.2% | -500.0% |